Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.02 USD
Change Today 0.00 / 0.00%
Volume 0.0
FCPG On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 03/19/15 All times are local (Market data is delayed by at least 15 minutes).

first china pharmaceutical g (FCPG) Snapshot

Open
$0.02
Previous Close
$0.02
Day High
$0.02
Day Low
$0.02
52 Week High
04/3/14 - $0.10
52 Week Low
03/11/15 - $0.02
Market Cap
1.2M
Average Volume 10 Days
5.2K
EPS TTM
$0.05
Shares Outstanding
59.7M
EX-Date
--
P/E TM
0.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for FIRST CHINA PHARMACEUTICAL G (FCPG)

Related News

No related news articles were found.

first china pharmaceutical g (FCPG) Related Businessweek News

No Related Businessweek News Found

first china pharmaceutical g (FCPG) Details

First China Pharmaceutical Group, Inc., through its subsidiary, Kun Ming Xin Yuan Tang Pharmacies Co. Ltd., engages in the drug logistics and distribution business in the People’s Republic of China. It is involved in the distribution of medicine products, Chinese patent drugs, herbs, pharmaceutical chemicals, biological products, antibiotics, biochemical drugs, clinical thermometers, blood pressure meters, and syringes. The company distributes its products to hospitals, clinics, pharmacies, drug stores, and other health care institutions through the Internet and local sub-distributors. First China Pharmaceutical Group, Inc. was founded in 2002 and is headquartered in Kunming City, the People’s Republic of China.

98 Employees
Last Reported Date: 11/19/12
Founded in 2002

first china pharmaceutical g (FCPG) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

first china pharmaceutical g (FCPG) Key Developments

SEC Orders Hearing On Registration Suspension Or Revocation Against First China Pharmaceutical Group, Inc. For Failure To Make Required Periodic Filings

Securities and Exchange Commission (SEC or the commission) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of First China Pharmaceutical Group, Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company was delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.

First China Pharmaceutical Group, Inc. Appoints Marcum Bernstein & Pinchuk LLP as its Independent Registered Public Accounting Firm

On December 9, 2013, the Audit Committee of the Board of Directors of First China Pharmaceutical Group, Inc. engaged Marcum Bernstein & Pinchuk LLP as its independent registered public accounting firm to audit the company's financial statements for the company's current fiscal year ending December 31, 2012 and the fiscal year ended December 31, 2013. The engagement was approved by the Board of Directors of the company on December 13, 2013.

EFP Rotenberg LLP Resigns as Independent Registered Public Accounting Firm, But First China Pharmaceutical Group, Inc Declines to Accept Resignation of EFP Rotenberg LLP

Effective September 3, 2013, EFP Rotenberg LLP resigned as the independent registered public accounting firm of First China Pharmaceutical Group, Inc. The company's Board of Directors informed EFP that it would not accept their resignation. EFP maintains that it resigned due to an outstanding amount of $40,000 relating to its audit of the company's financial statements for the fiscal year ended December 31, 2012 (the 2012 Audit). However, the company previously on August 6, 2013 offered to pay the $40,000 to EFP in advance of completion of the 2012 Audit if a memorandum of understanding was signed and sent to the company. EFP ignored this communication as well as other communications from the company. The company also requested EFP's reassurance in writing that if all payments are made, the 2012 Audit and related filings will be made. The company made this request because of EFP's unresponsive behavior to the Company's attempts to finalize the memorandum of understanding.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FCPG:US $0.02 USD 0.00

FCPG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FCPG.
View Industry Companies
 

Industry Analysis

FCPG

Industry Average

Valuation FCPG Industry Range
Price/Earnings 0.4x
Price/Sales 0.0x
Price/Book NM Not Meaningful
Price/Cash Flow 0.4x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FIRST CHINA PHARMACEUTICAL G, please visit www.firstchinapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.